University of Pittsburgh Brain Health Initiative
David Okonkwo, MD, PhD · with National Football League, Avid Radiopharmaceuticals · NCT04708613
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 29–59 · Men only
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 300
- US sites recruiting
- 1
- Study start
- November 18, 2019
- Record last updated
- June 22, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This project will define the prevalence of brain health (i.e., normal cognitive, neuromotor, behavioral function) in living professional football retirees and group-matched controls through a comprehensive assessment of clinical, neuroimaging, and biomarker measures.
Being studied: Cognitive/Neuropsychological Testing; Vestibular/Ocular-Motor Testing; Sleep Evaluation; MRI, High-Resolution; Health & Physical Exam; Physical Function; Blood Testing and Biomarker Analysis; Applanation Tonometry; PET brain imaging; [C-11]6-OH-BTA-1; [F-18]AV-1451
Conditions: Traumatic Brain Injury
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion criteria
Former professional football player/exposed group:
- Professional football retiree aged 29-59
- Played a minimum of 3 professional football seasons, with a minimum of 3 games in each season
- Fluent in English (translations are not available/validated for most neuropsychological tests)
Control/unexposed group
- Age 29-59 male
- High school education or beyond
- Fluent in English (translations are not available/validated for most neuropsychological tests)
Exclusion criteria
Control/unexposed group
- Played organized football beyond high school
- History of severe TBI
- Current unstable cardiovascular disorder
For both groups
- Prior history of psychosis (such as schizophrenia), or other major neurological disorder that would interfere with testing, in the opinion of the primary investigator.
- Contraindication to MR imaging, such as ferrous metal, pacemakers, or concerns about claustrophobia
Recruiting US locations
University of Pittsburgh Department of Neurosurgery
Pittsburgh, PA 15213
Site contact: Kathryn Edelman, MS · 412-624-1077 · dunfeekl@upmc.edu
Study contacts (from the official record)
- Kathryn L Edelman, MS · 412-624-1077 · dunfeekl@upmc.edu
Similar studies in Pennsylvania
All neurology studies in Pennsylvania →- RecruitingPhase 1/Phase 2Overnight stay mentioned
Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS
Vector Y Therapeutics
- Location
- Philadelphia, PA + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersEarly Phase 1
Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
University of Pennsylvania
- Location
- Philadelphia, PA + 2 other US sites
- Eligibility basics
- Ages 40–85
- RecruitingHealthy volunteersEarly Phase 1
Localizing Epileptic Networks Using MRI and iEEG
University of Pennsylvania
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersEarly Phase 1
Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15
University of Pennsylvania
- Location
- Philadelphia, PA
- Eligibility basics
- Ages 40–80